{"id":"W4414913279","doi":"10.1200/op.2025.21.10_suppl.409","title":"Estimating meaningful change thresholds (MCTs) for selected scales from the European Organisation for Research and Treatment of Cancer (EORTC) questionnaires in the phase 3 SERENA-6 trial in patients with hormone receptor-positive/human epidermal growth factor receptor 2–negative advanced breast cancer (ABC).","year":2025,"lang":"en","type":"article","venue":"JCO Oncology Practice","topic":"Estrogen and related hormone effects","field":"Biochemistry, Genetics and Molecular Biology","cited_by":0,"is_retracted":false,"has_abstract":true,"ca_institutions":"AstraZeneca (Canada)","funders":"","keywords":"Quality of life (healthcare); Clinical trial; Breast cancer; Cancer; Aromatase inhibitor; Phases of clinical research; Patient-reported outcome; Correlation","routes":{"ca_aff":true,"ca_fund":false,"ca_venue":false,"about_ca":false,"invisible_to_affiliation_only":false},"retraction":null,"screen":null,"direct_labels":[],"prediction":{"model_version":"codex-gemma-dda1882f352a","candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.0007041645,0.0001805846,0.0002534179,0.00007077845,0.0002862533,0.00003053455,0.0001457892,0.0001657048,0.000004125198],"category_scores_gemma":[0.0007620382,0.0001111485,0.00003337242,0.0002425685,0.0002046301,0.00005245375,0.00003920776,0.0002152877,3.462521e-7],"about_ca_system_candidate":false,"about_ca_system_consensus":false,"about_ca_system_score_codex":0.0002388475,"about_ca_system_score_gemma":0.0002254841,"about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_topic_score_codex":0.001626806,"about_ca_topic_score_gemma":0.00175333,"domain_scores_codex":[0.9975859,0.00132917,0.0003003366,0.0003816001,0.0001361524,0.000266878],"domain_scores_gemma":[0.997484,0.001540585,0.0003005859,0.0001568485,0.0004826665,0.00003526135],"domain_codex":null,"domain_gemma":null,"domain_candidate":null,"domain_consensus":null,"study_design_codex":"randomized_trial","study_design_gemma":"observational","study_design_scores_codex":[0.3298868,0.009280439,0.1067345,0.000122496,0.001788448,0.00001152425,0.0186037,0.0001193646,0.2445233,0.000364055,0.001945451,0.2866199],"study_design_scores_gemma":[0.1741134,0.03283999,0.7209176,0.0004247136,0.0004824328,0.000005990138,0.003144512,0.000390037,0.06486696,0.0002245571,0.002036305,0.0005534922],"study_design_candidate":"observational","study_design_consensus":null,"genre_codex":"empirical","genre_gemma":"empirical","genre_scores_codex":[0.9923604,0.0009240284,0.00009061834,0.002842441,0.0001366072,0.003214754,0.0003442467,0.000007860591,0.00007910371],"genre_scores_gemma":[0.9961755,0.0004484539,0.001324488,0.0001300174,0.0002838598,0.001186869,0.0004123054,0.00002374254,0.00001473134],"genre_candidate":"empirical","genre_consensus":"empirical","teacher_disagreement_score":0.6141831,"threshold_uncertainty_score":0.4532506,"prediction_status":"machine_predicted_unvalidated"},"machine_scores":{"provisional":true,"baseline":true,"maturity_gate_passed":false,"score_opus":0.03338847961038326,"score_gpt":0.3878710757021117,"score_spread":0.3544825960917284,"validation_status":"score_only:v0-immature-baseline","note":"Baseline scores from an immature model (maturity gate not passed). Scores rank; they never assert a category."}}